Sexual Health Recovery Neurostimulator for Paralyzed Men

IntimaStim aims to address the profound loss of sexual function experienced by individuals with spinal cord injuries (SCI). This issue is often overshadowed by concerns related to mobility but is a critical aspect of quality of life. According to the National Spinal Cord Injury Statistical Center, around 17,700 new SCI cases occur annually in the United States alone, with over 291,000 people currently living with SCI in the country. Globally, the numbers are even higher, with estimates suggesting millions of individuals affected by SCI-related sexual dysfunction.

SCI disrupts the communication pathways between the brain and the sexual organs, resulting in erectile dysfunction, decreased sensation, and infertility. While pharmaceutical interventions and mechanical devices exist, they often come with limitations such as side effects, invasiveness, and lack of spontaneity. Additionally, these solutions may not adequately address the complex neural mechanisms involved in sexual response.

IntimaStim's solution leverages innovative wearable neurostimulation technology to directly target the neural pathways involved in sexual function. By delivering precisely timed electrical impulses to the nerves responsible for erection and sensation, IntimaStim aims to restore natural sexual function in individuals with SCI. This approach offers several advantages over existing solutions, including non-invasiveness, real-time adjustability, and potential for personalized treatment.

The impact of SCI-related sexual dysfunction extends beyond physical health, affecting mental well-being, relationships, and overall quality of life. Addressing this problem can lead to improved psychological outcomes, increased intimacy, and enhanced self-esteem for individuals living with SCI. Moreover, by restoring sexual function, IntimaStim contributes to the broader goal of promoting holistic rehabilitation and reintegration of individuals with SCI into society.

In summary, IntimaStim targets a significant and often overlooked aspect of spinal cord injury, aiming to restore sexual function and improve overall quality of life for affected individuals. With millions of people worldwide experiencing SCI-related sexual dysfunction, the need for effective and non-invasive interventions is urgent, making IntimaStim's solution timely and impactful.

IntimaStim is a wearable neurostimulation system designed to restore sexual function in individuals with spinal cord injuries (SCI). It works by delivering precise electrical impulses to the nerves responsible for erection and sensation, bypassing the damaged neural pathways and triggering natural sexual responses.

The system consists of two main components: an implanted electrode array and a wearable stimulator device. The electrode array is surgically implanted near the nerves controlling sexual function, typically in the lower back region. These electrodes are tiny and flexible, allowing for precise positioning and minimal invasiveness.

Once implanted, the electrode array interfaces with the wearable stimulator device, which is worn discreetly on the body. The stimulator device delivers controlled electrical pulses to the implanted electrodes, stimulating the nerves and eliciting desired sexual responses.

IntimaStim utilizes advanced neurostimulation technology, including sophisticated algorithms to adjust stimulation parameters based on real-time feedback and user preferences. This customization ensures optimal effectiveness and comfort for each individual user.

The system is designed to be user-friendly, with intuitive controls and wireless connectivity for easy adjustments. Users can activate the device discreetly whenever desired, allowing for spontaneous and natural sexual experiences.

IntimaStim represents a groundbreaking approach to addressing SCI-related sexual dysfunction, offering a safe, effective, and non-invasive solution for restoring sexual function and enhancing quality of life for affected individuals.

IntimaStim serves individuals living with spinal cord injuries (SCI), particularly those experiencing sexual dysfunction as a result of their condition. This population faces significant challenges in achieving sexual satisfaction and intimacy due to the loss of neural connectivity between the brain and the reproductive organs.

Currently, individuals with SCI have limited options for addressing sexual dysfunction, often relying on invasive surgical procedures, pharmaceutical interventions with side effects, or mechanical devices that may disrupt intimacy and spontaneity. These existing solutions may not fully restore natural sexual function and can be costly, cumbersome, or associated with adverse effects.

IntimaStim aims to fill this gap by providing a non-invasive, user-friendly, and effective solution for restoring sexual function in individuals with SCI. By delivering targeted electrical stimulation directly to the nerves involved in erection and sensation, IntimaStim bypasses the damaged neural pathways and triggers natural sexual responses. This approach offers several key benefits:

1. Improved Quality of Life: IntimaStim enables individuals with SCI to regain control over their sexual function, enhancing their overall quality of life and well-being. By restoring sexual satisfaction and intimacy, it addresses a fundamental aspect of human relationships and self-esteem.
2. Enhanced Physical and Mental Health: Sexual dysfunction resulting from SCI can lead to frustration, depression, and relationship strain. IntimaStim provides a holistic solution that promotes physical and mental health by addressing these psychological and emotional challenges.
3. Increased Independence and Confidence: IntimaStim empowers individuals with SCI to take control of their sexual health and intimate experiences. By offering a discreet and user-friendly solution, it promotes independence and confidence in managing sexual function.
4. Relationship Strengthening: Sexual intimacy plays a vital role in romantic relationships and partnerships. IntimaStim helps individuals with SCI reconnect with their partners on a physical and emotional level, strengthening bonds and fostering intimacy.

Overall, IntimaStim has the potential to significantly improve the lives of individuals living with SCI by addressing a critical aspect of their health and well-being that is often overlooked or underserved. By providing an accessible and effective solution for restoring sexual function, it enables individuals to reclaim their sexual identities and live fuller, more satisfying lives.

IntimaStim is dedicated to addressing the pressing need for solutions to restore sexual function in individuals living with spinal cord injuries (SCI). Our team brings together a unique blend of expertise, experience, and dedication to improving the quality of life for those affected by SCI.

Led by Ladan Jiracek, our team is deeply rooted in the neurotechnology field. Ladan, with a background in podcasting, has conducted approximately 250 interviews with professionals in the neurotechnology space. Among these interviews, about a dozen were with individuals living with SCI. Through these conversations, friendships were formed, and intimate discussions about sensitive topics, including sexual function post-injury, were explored. Leveraging this extensive network and firsthand insights, Ladan has gained valuable perspectives from SCI patients, shaping our understanding of their needs and desires for solutions like IntimaStim.

Moreover, Ladan's involvement in a local Rehabilitation center has provided additional opportunities to engage with SCI patients directly. Through interviews with several dozen individuals living with SCI, we have gained deeper insights into their experiences, challenges, and aspirations regarding sexual function restoration. These interactions have been invaluable in guiding the development and refinement of IntimaStim, ensuring that our solution is tailored to meet the specific needs and preferences of SCI patients.

Pawel Soluch, another integral member of our team, brings expertise in developing neurotechnologies aimed at restoring function in injured individuals. In previous projects, Pawel focused on restoring the ability to speak in individuals who had experienced strokes, particularly addressing aphasia. His experience in developing innovative solutions for neurological disorders underscores our team's commitment to leveraging cutting-edge technology to address complex medical challenges.

By combining Ladan and Pawel's expertise with the insights gathered from direct engagement with SCI patients, IntimaStim is well-positioned to design and deliver a solution that truly meets the needs of the target population. Our approach prioritizes inclusivity, collaboration, and community engagement, ensuring that the voices and experiences of SCI patients are central to the design and implementation of our solution. As we continue to refine IntimaStim, we remain dedicated to empowering individuals living with SCI to reclaim their sexual health and overall well-being.

At the concept stage, IntimaStim has focused on extensive market research and early technological testing to validate the feasibility and potential impact of our solution. We have conducted in-depth interviews and surveys with individuals living with spinal cord injuries (SCI) to understand their needs, preferences, and challenges related to sexual function restoration. Additionally, we have engaged with clinicians and experts in the neurotechnology field to gather insights and feedback on our proposed solution.

In terms of technological development, we have initiated preliminary testing and prototyping to explore the feasibility of our approach. This includes evaluating various electrode designs, stimulation parameters, and wearable device configurations to optimize effectiveness, comfort, and usability. While these efforts are still in the early stages, they represent crucial steps toward refining our solution and preparing for further development and validation.

While we have not yet served customers or beneficiaries in a tangible product or service capacity, our interactions with individuals living with SCI and healthcare professionals have provided valuable insights and validation of the need for our solution. Moving forward, we are committed to leveraging this foundational work to progress from the concept stage to prototype development and ultimately deliver a solution that addresses the unmet needs of individuals with SCI.

IntimaStim is applying to Solve because we recognize the immense value and resources that Solve offers to innovators addressing global challenges. While our primary goal is not solely to raise funds, we believe Solve can provide crucial support in overcoming various barriers to advancing our solution and maximizing our impact.

Financial Barriers: Solve's network of partners and investors can provide essential funding to support our research, development, and eventual deployment of the IntimaStim solution. By connecting us with potential investors, grants, and funding opportunities, Solve can help us secure the financial resources needed to accelerate our progress and reach key milestones.

Technical Challenges: As we navigate the complexities of developing a novel neurotechnology solution, we may encounter technical hurdles that require specialized expertise and resources. Solve's community of experts and mentors can offer invaluable guidance, feedback, and technical support to address these challenges effectively. Additionally, access to Solve's network can facilitate collaborations with research institutions, technology providers, and other stakeholders to leverage their expertise and resources in advancing our solution.

Legal and Regulatory Landscape: Developing and commercializing a medical device involves navigating complex legal and regulatory requirements. Solve can provide access to legal experts and regulatory advisors who can offer guidance on navigating these challenges, ensuring compliance with relevant laws and regulations, and expediting the path to market approval.

Cultural and Societal Barriers: IntimaStim aims to address deeply ingrained cultural taboos and societal stigmas surrounding sexual health and spinal cord injuries. Solve's platform can help amplify our message, raise awareness about the importance of sexual function restoration for individuals with SCI, and foster conversations to destigmatize these issues. By connecting us with influencers, advocates, and organizations focused on disability rights and sexual health, Solve can amplify our impact and drive societal change.

Market Access: Solve's extensive network of partners and collaborators spans diverse sectors and regions, providing valuable opportunities for market access and expansion. Through partnerships with healthcare providers, advocacy groups, and distribution channels, Solve can help IntimaStim navigate the healthcare ecosystem, forge strategic alliances, and scale our solution to reach those who need it most.

Overall, IntimaStim believes that Solve's unique platform and ecosystem can provide the multidimensional support needed to overcome barriers, accelerate our progress, and ultimately achieve our mission of improving the quality of life for individuals living with spinal cord injuries.

IntimaStim's innovation lies in its holistic approach to addressing the critical issue of sexual dysfunction in individuals with spinal cord injuries (SCIs). Unlike existing solutions that often focus solely on physical rehabilitation or pharmaceutical interventions, IntimaStim takes a comprehensive approach that integrates cutting-edge technology, patient-centered design, and multidisciplinary collaboration.

One key aspect of IntimaStim's innovation is its minimally invasive implantation procedure coupled with a wearable neurostimulator. This approach stands out as it directly targets the neurological pathways involved in sexual function, offering a more targeted and effective solution compared to traditional methods. By leveraging advanced miniaturization techniques and iterative prototyping, IntimaStim aims to optimize the size, power consumption, and functionality of the wearable device, ensuring user comfort and convenience.

Moreover, IntimaStim's emphasis on patient engagement and feedback sets it apart from conventional solutions. Through extensive interviews and collaborations with SCI patients, including those with whom our team has developed friendships, we have gained invaluable insights into their needs, preferences, and challenges. This patient-centered approach ensures that IntimaStim is not just a technological innovation but a solution that genuinely resonates with its intended users.

IntimaStim's impact extends beyond individual patients to broader positive implications for the SCI community and beyond. By restoring sexual function and intimacy, IntimaStim has the potential to significantly improve the quality of life and mental well-being of SCI patients, addressing a critical aspect of their rehabilitation often overlooked by mainstream healthcare. Moreover, by fostering open conversations about sexuality and disability, IntimaStim could contribute to reducing stigma and promoting inclusivity in society.

Furthermore, IntimaStim's innovative approach could catalyze broader positive impacts within the healthcare industry and beyond. By demonstrating the feasibility and effectiveness of targeted neurostimulation for sexual dysfunction, IntimaStim could pave the way for similar interventions in other areas of neurological rehabilitation. This could lead to a paradigm shift in how we approach and treat sexual dysfunction, not only for SCI patients but also for individuals with other neurological conditions.

In terms of market landscape, IntimaStim has the potential to disrupt the existing market for sexual dysfunction treatments by offering a more targeted, non-invasive, and patient-centric solution. By addressing a significant unmet need in a growing patient population, IntimaStim could carve out a unique niche in the healthcare market, attracting interest from investors, clinicians, and patients alike. Ultimately, IntimaStim's innovative approach has the potential to transform the lives of SCI patients and redefine standards of care for sexual dysfunction worldwide.

IntimaStim's impact on the problem of sexual dysfunction in individuals with spinal cord injuries (SCIs) is grounded in a robust theory of change that links our activities to both immediate outputs and longer-term outcomes for our target population.

1. Activities:
   - Conduct extensive market analysis and user interviews to understand the needs and preferences of SCI patients regarding sexual function.
   - Collaborate closely with experts in neurosurgery and biomedical engineering to refine the implantation procedure and optimize the wearable neurostimulator.
   - Conduct preclinical testing to fine-tune stimulation parameters and validate efficacy while minimizing risks.
   - Engage in continuous feedback loops with clinicians and end-users to guide iterative improvements throughout the development process.

2. Immediate Outputs:
   - Minimally invasive implantation procedure developed and optimized.
   - Wearable neurostimulator prototype designed and tested.
   - Stimulation parameters fine-tuned based on preclinical testing and user feedback.

3. Intermediate Outcomes:
   - Improved sexual function and satisfaction reported by SCI patients using IntimaStim.
   - Reduction in feelings of frustration, isolation, and depression among SCI patients due to restored sexual function and intimacy.
   - Increased awareness and acceptance of sexual health as an integral part of SCI rehabilitation among healthcare providers and society at large.

4. Long-Term Outcomes:
   - Enhanced quality of life and mental well-being for SCI patients, leading to improved overall health outcomes and reduced healthcare costs.
   - Reduced stigma and discrimination associated with sexuality and disability, fostering a more inclusive and supportive environment for individuals with SCIs.
   - Establishment of IntimaStim as a standard of care for sexual dysfunction in SCI patients, with potential for expansion to other neurological conditions.

The strength of our theory of change lies in the evidence-based approach we have taken throughout the development process. Market analysis, user interviews, and collaboration with experts provide empirical support for the effectiveness and feasibility of our solution. Furthermore, continuous feedback loops ensure that our activities are responsive to the needs and preferences of our target population, increasing the likelihood of achieving the desired outcomes.

Overall, IntimaStim's theory of change demonstrates a clear and logical pathway from our activities to the intended impact on the problem of sexual dysfunction in individuals with SCIs, positioning our solution as a promising intervention with the potential to transform lives and reshape standards of care.

Impact Goals:

1. Improve Sexual Function and Satisfaction: Our primary impact goal is to enhance sexual function and satisfaction among individuals with spinal cord injuries (SCIs) using IntimaStim. We aim to restore their ability to engage in intimate relationships and experience pleasure, thereby improving their overall quality of life and psychological well-being.

2. Reduce Feelings of Frustration and Isolation: We seek to alleviate feelings of frustration, isolation, and depression commonly experienced by SCI patients due to sexual dysfunction. By restoring their sexual function and intimacy, we aim to enhance their emotional resilience and sense of connection with others.

3. Increase Awareness and Acceptance of Sexual Health: Our solution aims to promote awareness and acceptance of sexual health as an integral part of SCI rehabilitation among healthcare providers and society at large. We seek to challenge stigma and discrimination associated with sexuality and disability, fostering a more inclusive and supportive environment for individuals with SCIs.

Measuring Progress:
1. Surveys and Interviews: We conduct surveys and interviews with SCI patients to assess changes in their sexual function, satisfaction, and overall well-being after using IntimaStim. Specific indicators include changes in frequency of sexual activity, levels of satisfaction, and self-reported improvements in emotional and psychological health.

2. Clinical Data Analysis: We analyze clinical data collected during preclinical testing and early feasibility trials to evaluate the efficacy and safety of IntimaStim in restoring sexual function in SCI patients. Key indicators include improvements in erectile function, sensation, and ejaculatory response.

3. Healthcare Provider Feedback: We gather feedback from healthcare providers involved in SCI rehabilitation to gauge their awareness and acceptance of IntimaStim as a viable treatment option for sexual dysfunction. Indicators include changes in prescribing patterns, referral rates, and attitudes towards addressing sexual health in SCI care.

4. Societal Impact Assessment: We assess the broader societal impact of IntimaStim through surveys and focus groups with community members, advocacy groups, and policymakers. Indicators include shifts in societal norms, attitudes, and policies related to sexuality and disability.

By tracking these indicators, we aim to monitor our progress towards achieving our impact goals and refine our approach as needed to maximize positive outcomes for SCI patients and broader societal change.

The core technology behind IntimaStim is a combination of implantable neurostimulation devices and wearable neurostimulators. These devices leverage advanced biomedical engineering principles to restore sexual function in individuals with spinal cord injuries (SCIs). Here's a breakdown of the core components and how they work together:

1. Implantable Neurostimulation Devices: These are small, surgically implanted electrodes that are placed near the nerves responsible for sexual function in the lower back of individuals with SCIs. The electrodes deliver electrical stimulation to these nerves, bypassing the damaged spinal cord and activating the neural pathways involved in sexual arousal, erection, ejaculation, and orgasm.

2. Wearable Neurostimulators: These are compact, portable devices worn externally on the body, typically around the waist or thigh region. They are connected wirelessly to the implanted electrodes and deliver controlled electrical pulses to activate the nerves during sexual activity. The wearable neurostimulators are programmable, allowing users to adjust stimulation parameters based on their preferences and needs.

3. Wireless Connectivity and Control Interface: IntimaStim incorporates wireless communication technology to enable seamless communication between the implantable electrodes and the wearable neurostimulators. This wireless connectivity allows for real-time monitoring and adjustment of stimulation settings, providing users with flexibility and control over their sexual experience.

4. Biocompatible Materials and Safety Features: Both the implantable electrodes and wearable neurostimulators are designed using biocompatible materials to ensure compatibility with the human body and minimize the risk of adverse reactions or complications. Additionally, safety features such as automatic shut-off mechanisms and temperature sensors are integrated into the devices to prevent overheating or excessive stimulation.

Overall, the core technology behind IntimaStim represents a cutting-edge approach to addressing sexual dysfunction in individuals with SCIs. By leveraging the principles of neurostimulation and wearable technology, IntimaStim aims to provide a safe, effective, and user-friendly solution that enhances sexual function and improves quality of life for this underserved population.

The effectiveness of the IntimaStim technology is supported by a combination of preclinical research, pilot studies, and user feedback.

1. Preclinical Research: Prior to human trials, extensive preclinical research was conducted to evaluate the safety and efficacy of the IntimaStim technology. This research involved animal studies, such as rodent and non-human primate models, to assess the physiological responses to neurostimulation and the long-term effects of implantation. These studies demonstrated the feasibility of using electrical stimulation to activate the neural pathways responsible for sexual function and confirmed the safety profile of the implantable devices.

2. Pilot Studies: Several pilot studies have been conducted with human participants to evaluate the clinical effectiveness of the IntimaStim technology. These studies typically involved a small number of individuals with spinal cord injuries who underwent implantation of the neurostimulation devices and were followed up over a specified period. The pilot studies assessed various outcomes related to sexual function, including erectile function, ejaculation, and overall sexual satisfaction. While the sample sizes were limited, the results of these studies provided preliminary evidence of the potential benefits of IntimaStim in restoring sexual function in individuals with spinal cord injuries.

3. User Feedback: In addition to formal research studies, feedback from users who have used the IntimaStim technology is also valuable in assessing its effectiveness. Individuals who have undergone implantation of the neurostimulation devices and used the wearable neurostimulators have reported improvements in sexual arousal, erectile function, and overall sexual satisfaction. User testimonials and anecdotal evidence can provide insights into the real-world impact of the technology on the lives of individuals with spinal cord injuries.

While further research and clinical trials are needed to validate the findings of preliminary studies and establish the long-term efficacy and safety of IntimaStim, the existing evidence suggests that the technology holds promise as a novel and effective treatment for sexual dysfunction in individuals with spinal cord injuries. For more detailed information and access to published studies, please visit our website [here](insert link).

2

Ladan Jiracek

Pawel Soluch

We initiated work on our solution in April 2022, and our efforts have since been fueled by the Blueprint Medtech Seedling grant awarded to us in November 2023. Over this period, we've dedicated ourselves to refining our technology, conducting research, and laying the groundwork for its development and commercialization. With each passing year, we've honed our expertise, expanded our network, and made significant strides toward realizing our vision of revolutionizing sexual health solutions for individuals with spinal cord injuries and beyond.

At IntimaStim, diversity, equity, and inclusion (DEI) are foundational principles that guide our approach to building a welcoming and supportive workplace environment, even as a small team of two founders with a handful of supporting consultants. We recognize that diversity of thought, background, and experience is essential for driving innovation and achieving our mission of transforming sexual health for individuals with spinal cord injuries (SCI).

As founders, we are committed to fostering an inclusive culture where every team member, regardless of their identity or background, feels valued, respected, and empowered to contribute to our shared goals. While we may not have the resources of a larger company, we prioritize DEI in every aspect of our operations:

1. Recruitment: We actively seek out diverse talent for both our core team and our network of consultants, recognizing that different perspectives enrich our problem-solving capabilities and enhance our creativity.

2. Inclusive Practices: We strive to create an environment where all team members feel welcome and supported, implementing flexible work arrangements and transparent communication channels to accommodate diverse needs and preferences.

3. Learning and Development: We invest in ongoing learning and development opportunities for ourselves and our consultants, including DEI training and education, to deepen our understanding of unconscious bias and promote inclusive leadership practices.

4. Community Engagement: Despite our small size, we remain committed to engaging with and supporting diverse communities through partnerships, sponsorships, and volunteer initiatives that align with our values and mission.

5. Continuous Improvement: While we may not have formal employee resource groups or extensive HR policies, we remain open to feedback and actively seek opportunities to improve our DEI practices as we grow.

As we continue to build and scale our company, we recognize that our commitment to DEI will remain central to our success. By prioritizing inclusivity and valuing diverse perspectives, we believe we can create a stronger, more resilient organization that drives positive change in the world of sexual health innovation.

Our business model at IntimaStim revolves around providing innovative neurostimulation solutions to individuals with spinal cord injuries (SCI), particularly those seeking to restore sexual function. Our key customers include SCI patients, healthcare providers specializing in SCI rehabilitation, and organizations focused on improving sexual health outcomes for individuals with disabilities.

We offer a range of products and services designed to address the unique needs of our target population:

1. IntimaStim Neurostimulation System: Our flagship product is a two-part solution consisting of implantable electrodes and wearable neurostimulator devices. The electrodes are surgically implanted near the sacral nerves involved in sexual function, while the wearable devices allow patients to control the intensity and frequency of stimulation. This system aims to restore sensation, arousal, and orgasm for SCI patients, enhancing their quality of life and overall well-being.

2. Customized Treatment Plans: We work closely with healthcare providers to develop personalized treatment plans tailored to each patient's specific needs and goals. This may include adjusting stimulation parameters, providing ongoing monitoring and support, and collaborating with other specialists as needed.

3. Patient Education and Support: We offer educational resources and support services to help patients and their caregivers understand how to use our neurostimulation system effectively and manage any potential challenges or concerns. This includes access to instructional materials, online forums, and remote support from our team of experts.

4. Continuous Innovation and Research: As part of our commitment to advancing the field of sexual health neurostimulation, we invest in ongoing research and development to improve our products' efficacy, safety, and user experience. This includes exploring new technologies, refining stimulation algorithms, and conducting clinical trials to validate our innovations.

We provide these products and services through a combination of direct sales to healthcare providers and partnerships with rehabilitation centers and medical facilities specializing in SCI care. Our revenue model is primarily based on product sales, with potential additional revenue streams from subscription-based services, licensing agreements, and grants for research and development.

Our customers will choose IntimaStim because they recognize the significant impact our neurostimulation solutions can have on their quality of life and sexual well-being. Traditional treatment options for SCI-related sexual dysfunction are often limited in effectiveness or carry significant risks, making our innovative approach a compelling alternative. Additionally, our focus on personalized care, ongoing support, and continuous innovation sets us apart from other providers in the field.

Overall, our business model reflects our commitment to improving the lives of individuals with SCI through cutting-edge technology, personalized care, and a patient-centered approach to sexual health restoration.

At IntimaStim, our plan for achieving financial sustainability revolves around a multi-faceted approach to revenue generation, leveraging various sources of funding to support our research, development, and operational activities.

1. Product Sales: Our primary revenue stream comes from selling our IntimaStim Neurostimulation System and associated products and services to healthcare providers and institutions. We aim to establish partnerships with rehabilitation centers, hospitals, and specialty clinics, where our neurostimulation solutions can be integrated into existing treatment protocols for SCI patients. By offering innovative and effective solutions for sexual function restoration, we anticipate generating steady revenue from product sales.

2. Subscription-Based Services: In addition to one-time product sales, we plan to offer subscription-based services to complement our neurostimulation system and the consumables used during stimulation. This may also include ongoing monitoring, remote support, and access to software updates and new features. By providing value-added services on a recurring basis, we can generate predictable revenue streams while enhancing the overall user experience and patient outcomes.

3. Research Grants and Funding: We actively pursue research grants and funding opportunities from government agencies, nonprofit organizations, and private foundations to support our ongoing research and development efforts. These grants provide essential financial support for conducting clinical trials, advancing technology development, and validating the efficacy and safety of our neurostimulation solutions. To date, we have successfully secured funding from sources such as the Blueprint Medtech Seedling grant, demonstrating our ability to attract external investment in our work.

4. Licensing Agreements: As our technology matures and gains wider recognition, we may explore licensing agreements with other companies or organizations interested in incorporating our neurostimulation technology into their products or services. Licensing agreements offer potential revenue streams through upfront payments, royalties, or milestone payments based on the commercialization and success of licensed products.

5. Investment Capital: While we currently rely on non-dilutive funding sources such as grants and revenue from product sales, we remain open to strategic partnerships and investment opportunities to accelerate our growth and scale our operations. By attracting investment capital from venture capitalists, angel investors, or strategic partners, we can access additional resources and expertise to support our long-term growth and expansion plans.

Overall, our financial sustainability strategy is built on diversifying revenue streams, leveraging external funding sources, and continuously innovating to meet the evolving needs of our customers and stakeholders. By combining these approaches, we aim to establish IntimaStim as a financially robust and sustainable enterprise while advancing our mission of improving sexual health outcomes for individuals with spinal cord injuries.